6-(3,4-dichloro-benzyl)-2,3,4,6-tetrahydro-pyrimido[2,1-a]isoindol-6-ol

ID: ALA207416

Chembl Id: CHEMBL207416

PubChem CID: 15959157

Max Phase: Preclinical

Molecular Formula: C18H16Cl2N2O

Molecular Weight: 347.25

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  OC1(Cc2ccc(Cl)c(Cl)c2)c2ccccc2C2=NCCCN21

Standard InChI:  InChI=1S/C18H16Cl2N2O/c19-15-7-6-12(10-16(15)20)11-18(23)14-5-2-1-4-13(14)17-21-8-3-9-22(17)18/h1-2,4-7,10,23H,3,8-9,11H2

Standard InChI Key:  POVYIBBVKZDUQO-UHFFFAOYSA-N

Associated Targets(Human)

NFKB2 Tchem Nuclear factor NF-kappa-B complex (2307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Adra1d Alpha-1d adrenergic receptor (1475 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1a Alpha-1a adrenergic receptor (3346 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1b Alpha-1b adrenergic receptor (2470 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human immunodeficiency virus (3636 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
tat Human immunodeficiency virus type 1 Tat protein (75 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 347.25Molecular Weight (Monoisotopic): 346.0640AlogP: 3.85#Rotatable Bonds: 2
Polar Surface Area: 35.83Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.19CX Basic pKa: 5.23CX LogP: 4.16CX LogD: 4.16
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.90Np Likeness Score: -0.11

References

1. del Olmo E, Barboza B, Ybarra MI, López-Pérez JL, Carrón R, Sevilla MA, Boselli C, San Feliciano A..  (2006)  Vasorelaxant activity of phthalazinones and related compounds.,  16  (10): [PMID:16513345] [10.1016/j.bmcl.2006.02.003]
2. Bedoya LM, del Olmo E, Sancho R, Barboza B, Beltrán M, García-Cadenas AE, Sánchez-Palomino S, López-Pérez JL, Muñoz E, San Feliciano A, Alcamí J..  (2006)  Anti-HIV activity of stilbene-related heterocyclic compounds.,  16  (15): [PMID:16713260] [10.1016/j.bmcl.2006.04.087]

Source